Regional News Archives - Page 81 of 190 - Journal for Clinical Studies

Current Edition

Regional News

SGS Opens New State-of-the-Art Site for Clinical Research in Antwerp, Belgium

SGS officially opens its new clinical pharmacology research center on the Antwerp University Hospital site on October 26, 2021, in the presence of Frankie Ng, SGS C...

27 October 2021 Regional News clinical pharmacology research center | clinical research

Continue Reading →

Regional News

Novartis looks for silver lining in $2B canakinumab repurposing after 2nd lung cancer failure

Is autoinflammatory disease treatment Ilaris a potential new therapy for non-small cell lung cancer (NSCLC)? After two pivotal trial failures, the answer seems to be ...

26 October 2021 Regional News Ilaris | lung cancer

Continue Reading →

Regional News

What would Medicare price negotiations bring to the US? Look to Europe, Lilly CEO Ricks says

When posed with the decades-old question of how drug price reform would affect their operations in the U.S., pharma execs have a ready-made response: Reducing drug pr...

26 October 2021 Regional News BioNTech | biotech

Continue Reading →

Regional News

Bristol Myers Squibb, after passing on Acceleron, now eyes Aurinia takeout: Bloomberg

It wasn't long ago that Bristol Myers Squibb ran the numbers on potentially buying Acceleron Pharma, but that deal didn't come together, and the biotech eventually so...

26 October 2021 Regional News Acceleron | Acceleron Pharma

Continue Reading →

Regional News

Oncopeptides’ shares crash as it pulls Pepaxto from the market, plans to shut down commercial units

Because its drug for relapsed or refractory multiple myeloma may increase the risk of death, Swedish biotech Oncopeptides has sidelined the treatment in the U.S., a m...

26 October 2021 Regional News Alzheimer | Committee for Medicinal Products for Human Use

Continue Reading →

Regional News

FDA greenlights Genentech’s eye implant for macular degeneration. Will it be a tough sell?

Two treatments per year as opposed to 12, what’s not to like? In two words—surgical implants. That’s the stigma Genentech will potentially face as it attempts to con...

26 October 2021 Regional News age-related macular degeneration | AMD

Continue Reading →

Regional News

Sanofi and Regeneron’s Dupixent aces another test, this time in the debilitating itch condition prurigo nodularis

Sanofi and Regeneron have big ambitions for immunology superstar Dupixent—envisioning the potential for $11 billion in annual sales. In acing a test in people with t...

26 October 2021 Regional News Dupixent | immunology

Continue Reading →

Regional News

Pfizer’s COVID-19 vaccine is safe, effective in kids ages 5 to 11, setting up possible FDA nod

Amid the nationwide COVID-19 vaccination campaign, youngsters 11 and under have been ineligible for shots—even though millions are back in school. With new Pfizer dat...

26 October 2021 Regional News COVID-19 | FDA

Continue Reading →

Regional News

Johnson & Johnson wins FDA panel backing for a second dose of its COVID shot but don’t call it a ‘booster’

Over the last year, the Johnson & Johnson COVID-19 vaccine has been commonly referred to as a single-shot alternative to the two-dose regimens of mRNA vaccines fr...

20 October 2021 Regional News COVID-19 | FDA

Continue Reading →

Regional News

Roche ushers early lung cancer into immunotherapy era with Tecentriq FDA approval. Will doctors follow?

Roche’s Tecentriq has ushered in a new era, offering the first immunotherapy option for non-small cell lung cancer (NSCLC) patients right after tumour surgery. But do...

20 October 2021 Regional News immunotherapy | lung cancer

Continue Reading →